{
    "Trade/Device Name(s)": [
        "Theranos Herpes Simplex Virus-1 (HSV-1) IgG Assay",
        "Theranos HSV-1 IgG Assay"
    ],
    "Submitter Information": "Theranos, Inc.",
    "510(k) Number": "K143236",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ"
    ],
    "Summary Letter Date": "June 29, 2015",
    "Summary Letter Received Date": "June 30, 2015",
    "Submission Date": "June 29, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "HSV-1 IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "K2-EDTA anticoagulated plasma (venous)",
        "K2-EDTA anticoagulated whole blood (fingerstick)"
    ],
    "Specimen Container(s)": [
        "Serum separator tube",
        "Theranos Capillary Tube",
        "Nanotainer Tube",
        "K2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Theranos System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Analyzer",
        "Specimen collection device",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Theranos HSV-1 IgG chemiluminescent immunoassay for qualitative detection of HSV-1 IgG antibodies in serum, plasma, and fingerstick whole blood using Theranos System.",
    "Indications for Use Summary": "Aids in presumptive diagnosis of HSV-1 infection in sexually active individuals and expectant mothers by qualitative detection of HSV-1 IgG antibodies in human serum, venous plasma, and fingerstick whole blood, not cleared for donor screening or pediatric/neonate use.",
    "fda_folder": "Microbiology"
}